Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05405166 |
| Title | SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM |
| Acronym | IRAKLIA |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Sanofi |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | TUR | SWE | POL | NOR | ITA | HUN | GRC | GBR | FRA | ESP | DEU | CZE | CAN | BRA | AUS | ARG |